Format

Send to

Choose Destination
J Clin Virol. 2010 May;48 Suppl 1:S14-9. doi: 10.1016/S1386-6532(10)70004-4.

Prevention strategies for herpes zoster and post-herpetic neuralgia.

Author information

1
Pediatric Infectious Diseases, University of Colorado Denver, Mail Stop C227, Building 401, 1784 Racine Street, Room R09-108, Aurora, CO 80045, USA. myron.levin@ucdenver.edu

Abstract

Impairment of varicella zoster virus (VZV)-specific cell-mediated immunity, including impairment due to immunosenescence, is associated with an increased risk of developing herpes zoster (HZ), whereas levels of anti-VZV antibodies do not correlate with HZ risk. This crucial role of VZV-specific cell-mediated immunity suggests that boosting these responses by vaccination will be an effective strategy for reducing the burden of HZ. Other strategies focus on preventing the major complication of HZ--post-herpetic neuralgia. These strategies include pre-emptive treatment with drugs such as tricyclic antidepressants, anticonvulsants and analgesics.

PMID:
20510262
PMCID:
PMC5391038
DOI:
10.1016/S1386-6532(10)70004-4
[Indexed for MEDLINE]
Free PMC Article

Supplemental Content

Full text links

Icon for Elsevier Science Icon for PubMed Central
Loading ...
Support Center